Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-3249-2018Class II

Vanguard 360 Revision Knee System 63x 10mm Universal Tibial Block Augment, Model Number 185221 Intended for...

Zimmer GmbH / initiated 2018-08-02 / Terminated / root cause: packaging

Zimmer Biomet, Inc. began a recall of Vanguard 360 Revision Knee System 63x 10mm Universal Tibial Block Augment, Model Number 185221 Intended for use in Total Knee Arthroplasty on . FDA classified it as Class II and gives the reason as "The implant only has one bolt in the sterile package but it should have had two". As of , the recall status on record is Terminated, and MDM tags the root cause as packaging.

Recall record

Recall number
Z-3249-2018
Classification
Class II
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
Zimmer GmbH
Product
Vanguard 360 Revision Knee System 63x 10mm Universal Tibial Block Augment, Model Number 185221 Intended for use in Total Knee Arthroplasty
Product code
JWH Prosthesis, Knee, Patellofemorotibial, Semi-Constrained, Cemented, Polymer/Metal/Polymer
Reason for recall
The implant only has one bolt in the sterile package but it should have had two.
Root cause tag
packaging
FDA root cause
Under Investigation by firm
Action
The firm, Zimmer Biomet, sent an "URGENT MEDICAL DEVICE RECALL" notification letters dated 8/2/18 to customers on 8/2/18. The letters described the product, problem and actions to be taken. The letters instruct customers to perform the following actions: Risk Manager Responsibilities: 1. Review this notification and ensure that affected personnel are aware of the contents. 2. If you have affected product at your facility, assist your Zimmer Biomet sales representative and quarantine all affected product. Your Zimmer Biomet sales representative will remove the affected product from your facility. 3. Complete Attachment 1 Certificate of Acknowledgement and send to [email protected]. This form must be returned even if you do not have affected products at your facility. 4. Retain a copy of the acknowledgement form with your recall records in the event of a compliance audit of your facilitys documentation. 5. If you have further questions or concerns after reviewing this notice, please call customer service at 574-371-3071 between 8:00 am and 5:00pm EST, Monday through Friday. Calls received outside of call center operating hours will receive a voicemail prompt or be transferred to an on-call representative in the event of an emergency. Alternatively, your questions may be emailed to [email protected]. Distributors: 1. Review this notification and ensure that affected team members are aware of the contents. 2. Immediately locate and quarantine affected product in your inventory. 3. Immediately return all affected product from your distributorship and from affected hospitals within your territory. a. Complete Attachment 1 Inventory Return Certification Form and send to [email protected] within three (3) days. b. For each return, send a copy of Attachment 1 to [email protected]. c. Include a hardcopy of Attachment 1 in each carton of your retur
Quantity in commerce
16
Distribution
Worldwide Distribution: US (nationwide) to the following US states: AZ, KS, NM, NV, and UT; and to countries of: Australia and Netherlands.
Product codes and lots
Lot 320390, UDI (01) 0088030448157 (17) 230129 (10) 320390

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-3249-2018
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-3249-2018Class IITerminatedVoluntary: Firm initiated
Z-3250-2018Class IITerminatedVoluntary: Firm initiated